ATE529118T1 - Antacid - Google Patents

Antacid

Info

Publication number
ATE529118T1
ATE529118T1 AT07850616T AT07850616T ATE529118T1 AT E529118 T1 ATE529118 T1 AT E529118T1 AT 07850616 T AT07850616 T AT 07850616T AT 07850616 T AT07850616 T AT 07850616T AT E529118 T1 ATE529118 T1 AT E529118T1
Authority
AT
Austria
Prior art keywords
hydrotalcite
particulate composite
particulate
composite hydrotalcite
antacid
Prior art date
Application number
AT07850616T
Other languages
English (en)
Inventor
Akira Okada
Keiko Katsuki
Original Assignee
Kyowa Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd
Application granted granted Critical
Publication of ATE529118T1 publication Critical patent/ATE529118T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/78Compounds containing aluminium and two or more other elements, with the exception of oxygen and hydrogen
    • C01F7/784Layered double hydroxide, e.g. comprising nitrate, sulfate or carbonate ions as intercalating anions
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00Compounds of aluminium
    • C01F7/78Compounds containing aluminium and two or more other elements, with the exception of oxygen and hydrogen
    • C01F7/784Layered double hydroxide, e.g. comprising nitrate, sulfate or carbonate ions as intercalating anions
    • C01F7/785Hydrotalcite
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/20Two-dimensional structures
    • C01P2002/22Two-dimensional structures layered hydroxide-type, e.g. of the hydrotalcite-type
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/50Solid solutions
    • C01P2002/52Solid solutions containing elements as dopants
    • C01P2002/54Solid solutions containing elements as dopants one element only
AT07850616T 2006-12-20 2007-12-14 Antacid ATE529118T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006341990 2006-12-20
PCT/JP2007/074112 WO2008075621A1 (ja) 2006-12-20 2007-12-14 制酸剤

Publications (1)

Publication Number Publication Date
ATE529118T1 true ATE529118T1 (de) 2011-11-15

Family

ID=39536252

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07850616T ATE529118T1 (de) 2006-12-20 2007-12-14 Antacid

Country Status (12)

Country Link
US (1) US8216608B2 (de)
EP (1) EP1967195B1 (de)
JP (1) JPWO2008075621A1 (de)
KR (1) KR101450912B1 (de)
CN (1) CN101365463B (de)
AT (1) ATE529118T1 (de)
DK (1) DK1967195T3 (de)
ES (1) ES2372429T3 (de)
PL (1) PL1967195T3 (de)
PT (1) PT1967195E (de)
TW (1) TW200826949A (de)
WO (1) WO2008075621A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI444190B (zh) * 2007-12-10 2014-07-11 Kyowa Chem Ind Co Ltd 潰瘍治療劑
ITBO20090070A1 (it) * 2009-02-12 2010-08-12 Monica Bonucci Farmaco per la stomatite aftosa
JP2010265207A (ja) * 2009-05-14 2010-11-25 Kyowa Chem Ind Co Ltd 膵臓機能強化乃至活性化用複合ハイドロタルサイト粒子
JP5910907B2 (ja) * 2010-02-19 2016-04-27 株式会社海水化学研究所 胃潰瘍治療剤
WO2017221498A1 (ja) * 2016-06-24 2017-12-28 日本碍子株式会社 層状複水酸化物を含む機能層及び複合材料
WO2017221451A1 (ja) * 2016-06-24 2017-12-28 日本碍子株式会社 層状複水酸化物を含む機能層及び複合材料

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539306A (en) * 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
JPS56158716A (en) 1980-05-14 1981-12-07 Kyowa Chem Ind Co Ltd Antacid preparation
GB8826333D0 (en) * 1988-11-10 1988-12-14 Unilever Plc Oral compositions
JP3465248B2 (ja) 1994-03-25 2003-11-10 株式会社海水化学研究所 抗微生物剤
JP3140408B2 (ja) * 1996-10-29 2001-03-05 協和化学工業株式会社 抗微生物剤
RU2177485C2 (ru) * 1997-07-04 2001-12-27 Киова Кемикал Индастри Ко., Лтд. Состав синтетической смолы, имеющей устойчивость к разрушению под действием тепла, и формованные изделия
JPH11222494A (ja) * 1997-11-21 1999-08-17 Sakai Chem Ind Co Ltd 金属錯体含有ハイドロタルサイト類化合物、抗菌剤、抗菌性樹脂組成物および抗菌性塗料組成物
JPH11240886A (ja) * 1997-11-21 1999-09-07 Sakai Chem Ind Co Ltd 金属錯体含有ハイドロタルサイト類化合物、抗菌剤、抗菌性樹脂組成物および抗菌性塗料組成物
JPH11180808A (ja) * 1997-12-18 1999-07-06 Kyowa Chem Ind Co Ltd 藻発生または微小生物の繁殖抑制剤およびその使用
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
JP4004160B2 (ja) * 1998-09-21 2007-11-07 協和化学工業株式会社 ウラン(u)含量の少ないハイドロタルサイト類化合物およびその製造法
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
JP4154460B2 (ja) * 2006-11-09 2008-09-24 株式会社海水化学研究所 抗潰瘍剤
WO2009093334A1 (ja) * 2008-01-25 2009-07-30 Kyowa Chemical Industry Co., Ltd. 制酸剤

Also Published As

Publication number Publication date
EP1967195A4 (de) 2010-06-09
PL1967195T3 (pl) 2012-03-30
CN101365463A (zh) 2009-02-11
US8216608B2 (en) 2012-07-10
CN101365463B (zh) 2010-12-08
JPWO2008075621A1 (ja) 2010-04-08
KR101450912B1 (ko) 2014-10-14
TW200826949A (en) 2008-07-01
PT1967195E (pt) 2011-12-22
DK1967195T3 (da) 2012-01-16
KR20090098940A (ko) 2009-09-18
EP1967195A1 (de) 2008-09-10
EP1967195B1 (de) 2011-10-19
US20090142394A1 (en) 2009-06-04
ES2372429T3 (es) 2012-01-19
WO2008075621A1 (ja) 2008-06-26

Similar Documents

Publication Publication Date Title
DK1967195T3 (da) Antacid
AR109135A2 (es) Forma sólida de una sal hidratada de tartrato de un compuesto de pirrolidina inhibidor de dpp-iv
WO2008051261A3 (en) Sealant composition containing inorganic-organic nanocomposite filler
WO2007074915A8 (en) Water-soluble benzoazepine compound and its pharmaceutical composition
EP2537857A3 (de) Mutante Formen von Streptolysin O
ATE494127T1 (de) Zusammensetzung
EP2412689A3 (de) Nano-Hybridbetonzusatzmittel für Chlorideindringwiderstand bestehend aus geschichtetem Doppelhydroxid-/Polyurethancopolymer
WO2007099548A3 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
MX2011001568A (es) Metodo para formar una bolsa.
WO2010090458A3 (ko) 유해조류 방제용 조성물
CY1108804T1 (el) Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
MX2009006638A (es) Agente para erradicar helicobacter pylori que tiene actividad inhibidora sobre la secrecion de acido gastrico.
TW200510410A (en) Cyclic benzimidazoles
WO2009037262A3 (en) Method of preventing early lawsonia intracellularis infections
BRPI0601114A (pt) composição herbicida, e método de preparação de uma composição herbicida
WO2009022540A1 (ja) 化合物及び感放射線性組成物
EA200900836A1 (ru) Способ получения высокочистой внутренней соли 3-карбокси-n,n,n-триметил-1-пропанаминий гидроксида
MY155591A (en) Agent for treating ulcer
DE502006006901D1 (de) Trinkflasche mit einem verschluss für eine einhandbedienung
TH111664A (th) ยาลดกรดกระเพาะอาหาร
CN103012980A (zh) 一种吸噪音排水管材料
WO2010018837A3 (ja) 蛋白質架橋阻害剤
EA201071205A1 (ru) Многослойная ткань теплового барьера
bin Abdul Rahman et al. Industri kapur di Malaysia (IN MALAY), Lime Industry in Malaysia (Paper B6)
RU2010128597A (ru) Вяжущее